gp100 (175-189)

gp100 (175-189) is a synthetic peptide corresponding to amino acid residues 175 through 189 of the human glycoprotein 100 (gp100), a well-characterized melanocyte differentiation antigen. As a defined peptide fragment, it is widely recognized in immunological and oncology research for its role in antigen processing and presentation, particularly in the context of melanoma studies. The sequence's immunogenic properties and relevance to T cell recognition make it a valuable tool for dissecting antigen-specific immune responses. Owing to its precise molecular identity and functional significance, gp100 (175-189) is frequently utilized in experimental systems requiring controlled peptide-based modulation or monitoring of cellular processes.

Epitope mapping: Researchers employ this peptide in the identification and characterization of T cell epitopes within the gp100 antigen. By providing a defined sequence, it enables detailed studies into the specificity of CD8+ and CD4+ T cell responses, facilitating the mapping of immunodominant regions recognized by the adaptive immune system. Such work is fundamental for understanding the molecular interactions that underpin antigen recognition and for refining immunological assays that depend on well-characterized peptide antigens.

Immunogenicity studies: The 175-189 fragment is extensively used to evaluate the immunogenic potential of gp100-derived sequences in various preclinical models. Scientists utilize it to stimulate peripheral blood mononuclear cells (PBMCs) or isolated T cell populations, assessing cytokine production, proliferation, and cytotoxic activity. These investigations provide critical insights into the mechanisms of antigen-specific immune activation and tolerance, informing the design of more effective immunological interventions and experimental vaccines.

Peptide-MHC binding assays: The defined sequence of gp100 (175-189) makes it an ideal candidate for studying peptide binding affinities to major histocompatibility complex (MHC) molecules. By incorporating this peptide into in vitro MHC binding assays, researchers can assess the stability and specificity of peptide-MHC complexes, which is essential for understanding antigen presentation pathways. Such studies support the rational design of peptide-based immunotherapeutics and enhance the predictive accuracy of epitope selection algorithms.

Functional T cell assays: In cellular immunology, this peptide is frequently used to stimulate antigen-specific T cell populations, enabling functional assays such as ELISPOT, intracellular cytokine staining, or flow cytometric analysis of activation markers. These applications are critical for quantifying T cell responses, evaluating immune competence, and characterizing the functional repertoire of T cells in experimental systems. The peptide's defined nature ensures reproducibility and specificity in these assays.

Peptide-based vaccine research: The gp100 (175-189) sequence serves as a model antigen in the development and optimization of peptide-based immunization strategies. Its use allows researchers to investigate the parameters influencing peptide uptake, processing, and presentation, as well as to test novel adjuvant formulations or delivery platforms. These studies contribute to the broader understanding of how synthetic peptides can be leveraged to direct and enhance antigen-specific immune responses in controlled experimental settings.

1. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

3. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

5. Implications of ligand-receptor binding kinetics on GLP-1R signalling